Particulate emboli capture by an intra-aortic filter device during cardiac surgery  by Reichenspurner, Hermann et al.
plague patients undergoing cardiac operations at a sig-
nificant rate. Age risk factors notwithstanding, it is a
widely held belief that the incidence of neurologic
injury after surgery is underestimated. In 1996, Roach
and colleagues1 published that the prevalence of stroke,
coma, seizure, and cognitive impairment is high and
ranges between 6.1% and 33%.2 The subtle and gross
manifestations of neurologic dysfunction potentially
result in significant cost to the patients, families, and
the health care system overall.
The pathogenesis of these neurologic and neurobe-
havioral sequelae is multifactorial, with studies indicat-
ing hypoperfusion, anesthesia, cardiopulmonary
bypass, and patient comorbidity among the potential
predisposing factors.2-8 Although the prevalence of each
of these contributors is not well understood, recent
studies have indicated that particulate embolization
(atheromatous or other nature) during surgical manipu-
D espite advances in technology (anesthesia, car-diopulmonary bypass circuits, techniques, and
instrumentation), neurologic sequelae continue to
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PARTICULATE EMBOLI CAPTURE BY AN INTRA-AORTIC FILTER DEVICE DURING CARDIAC SURGERY
lation of the aorta is significantly linked with neurolog-
ic complications.9-12 Gold and colleagues13 and Barbut
and colleagues14 assessed the timing and quantity of
microemboli release during cardiac surgical procedures
by means of transcranial Doppler scanning. They
demonstrated that up to 60% of perioperative emboli
are attributed to clamp manipulation, primarily clamp
removal, during cardiopulmonary bypass. These
emboli have the potential to cause widespread, devas-
tating, cerebral and peripheral ischemic damage when
released into the circulation.
These findings led to the assumption that providing a
means of filtration during unclamping of the aorta may
significantly reduce the incidence and severity of neu-
rologic injury related to particulate embolization. The
device and method of filtration were designed to elim-
inate a need for additional incisions into the aorta, as
well as to be ideally situated in the aorta for optimal
efficiency. Experimental studies of the device were per-
formed in vitro and in vivo to evaluate safety and effi-
ciency.15 Results demonstrated that the device was
atraumatic, had excellent thromboresistance, and was
effective at capturing particulate matter.
The purpose of this study was to evaluate, in human
subjects, the feasibility of a novel method of particulate
emboli filtration during routine cardiopulmonary
bypass, specifically during the period when the aorta is
unclamped. Furthermore, the study was aimed at eval-
uating the nature of captured particulate emboli by
means of histologic and scanning electron microscopy
analysis in a core laboratory.
Patients and methods
Patients undergoing cardiopulmonary bypass for cardiac
operations were considered for this study. Patient selection
was at the discretion of the investigator; however, only
patients with aortic aneurysm or congenital anomalies of the
aortic arch were excluded from the study. Additionally, can-
didates were limited to those undergoing median sternotomy
to avoid potential technical challenges related to lesser inva-
sive incisions. Seventy-nine patients who were selected and
gave consent for intra-aortic filtration were included in the
analysis from December 1997 to December 1998; 40 patients
were operated on in Munich, and 39 were operated on in
Buenos Aires. Protocol approval was obtained from institu-
tional review boards at the University Hospital Munich-
Grosshadern and the Italian Hospital of Buenos Aires, and all
patients signed an informed consent form.
After routine anesthesia induction, the aorta was evaluated
by palpation and transesophageal echocardiography (TEE)
for assessment of size, integrity, and presence of calcifica-
tion. An intra-aortic arterial filter (EMBOL-X, Inc, Mountain
View, Calif) size (extra small, small, medium, large, or extra
large) was selected on the basis of the TEE findings or exter-
nal measurement estimating the internal diameter of the
aorta.
Patients were then cannulated for cardiopulmonary bypass
per usual routines. A modified 24F arterial return cannula
(EMBOL-X, Inc) with a side port designed to house the fil-
tration device was inserted into the ascending aorta with dou-
ble purse-string sutures in accordance with standard surgical
technique (Fig 1). Choice of venous return cannula was at the
discretion of the surgeon.
After completion of the surgical procedure and before
removal of the aortic crossclamp, the intra-aortic filter was
then inserted through the side port of the arterial return can-
nula and remained in the ascending aorta until cardiopul-
monary bypass was discontinued (Fig 2). The filter device is
a butterfly net–type filter, which is provided in a cartridge
that locks into the filter lumen of the side port. The filter is
inserted into the aorta by depressing a syringe-like plunger
(Fig 1). The filter mesh had a pore diameter of 120 µm, and
the mesh was coated with heparin. The aortic clamp was then
removed, and the filter was left in place in the ascending aorta
during placement and removal of the partial occlusion clamp
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Fig 1. Intra-aortic filtration system composed of a modified 24F arterial perfusion cannula and 120-µm filter
(EMBOL-X).
and was withdrawn after the heart began to fully eject. Patient
hemodynamics, clotting times, and cardiopulmonary bypass
flow rates were monitored during filter deployment.
The filter was then removed from the aorta through the side
port. After the patient was fully weaned from cardiopul-
monary bypass, the purse-string sutures were loosened, the
arterial cannula was removed, and the sutures were pulled
tight to establish hemostasis.
All filters were visually inspected on removal for captured
material. Filters were collected in specimen tubes and fixed
with formalin for analysis. Particulate emboli were analyzed,
and filter analysis included gross visual examination at 10×
magnification to identify the particulate matter (with 74/77
[96%] having particulate matter). Particulate matter was col-
lected from 44 (59%) of 74 filters and sent to a central
pathology laboratory (Stanford University) for histologic
examination of the captured material. The histologic sections
were stained with hematoxylin and eosin, trichrome, and
elastica van Gieson’s stain. Histologic analysis included
examination for presence of platelets and fibrin deposition,
true thrombus, and/or blood clotting, grumous portion of
plaque-cholesterol, fibrous atheroma, or fibrous cap, and the
normal vessel wall.
Scanning electron microscopy was performed on a subset
(n = 12 [16%]) of filters with the longest dwell times to assess
thrombogenicity of the filter in the clinical application.
Clinical assessments included basic neurologic examina-
tions preoperatively, first day postoperatively, and before dis-
charge.
Results
A total of 79 patients were enrolled in the study.
Patient demographics represented the usual distribution
of age, sex, and aortic diameters (Table I). Procedures
consisted of regular coronary artery bypass grafting
(CABG) in 66%, isolated valve operations in 26%, and
combined procedures in 8% of the patients.
Average filter deployment duration was 26 minutes
(range, 5-58 minutes). Cardiopulmonary bypass times,
flow rates, and pressures were not compromised
because of the presence of the device and are listed in
Table II. The arterial cannula performance was found to
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Fig 2. Schematic of Embol-X Arterial Cannula and Filter System within the cardiopulmonary bypass circuit.
Table I. Patient characteristics
Patient demographics Mean Range
Age (y) 64 ± 10.6 41–85
Weight (kg) 75.6 ± 12.0 47–107
Sex, M/F (%) 73/27
Aortic characteristics
Diameter (cm) 3.3 ± 0.36 2.5–4.0
Wall thickness (mm) 1.1 ± 0.69 0.5–3.2
Table II. Procedural details and bypass data
Mean Range
Bypass time (min)
Bypass time 103 ± 29 50–197
Crossclamp time 67 ± 23 24–145
Bypass flow during filter dwell
Maximum flow (L/min) 4.5 ± 0.91 3.0–6.34
Minimum flow (L/min) 3.8 ± 0.75 1.82–5.46
Hemodynamic values during 
filter dwell
Mean arterial pressure 58 ± 9.3
(mm Hg)
Mean ACT (s) 557 ± 162.1
be equivalent to a standard 20F arterial cannula in
effective flow. Patient hemodynamics remained normal
throughout the filter dwell period in the aorta. Activated
clotting times (ACTs) during the procedure were main-
tained within normal limits, and during filter dwell
time, the mean ACT was 557 seconds.
Cardiopulmonary bypass peak flows and line pres-
sures were recorded on 7 patients in the initial series.
Mean flow rates (4.42 ± 0.47 L/min) and line pressures
(217 ± 27.8 mm Hg compared with 62.0 ± 6.9 mm Hg
mean arterial pressure) were found to be very similar
between patients and within normal limits expected for
a 20F arterial cannula. These clinical results also con-
firmed data previously obtained during in vitro and in
vivo animal testing before the human clinical study.
Further data were not collected because the values were
within the expected range; only minor variances exist-
ed between patients, and the information was not found
to be of clinical significance.
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Fig 3. Particulate emboli found in filter mesh (gross visual examination at 10× magnification). Patient was a 75-
year-old man who underwent aortic and mitral valve replacement and thrombus excision from the left atrium. The
filter was deployed for 32 minutes.
Fig 4. Scanning electron micrograph of filter mesh, showing
a relatively clean surface with scattered focal sites of platelet
and fibrin (magnification 20×). Patient was a 61-year-old
man with 3-vessel disease. The filter was deployed for 26
minutes.
Table III. Histology (n = 44)
Material No. %
Fibrous atheroma or fibrous cap 29/44 66
Platelet-fibrin 16/44 36
Thrombus and/or blood clot 11/44 25
Normal vessel wall 3/44 7
Grumous portion of 1/44 2
plaque-cholesterol
Hyaline cartilage 1/44 2
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Fig 5. Elastica van Gieson stain demonstrating fibrous atheroma. Stain highlights irregularly arranged collagen
and elastic fibrils, suggesting fibrous cap or fibrous atheroma containing aggregates of fibrin and fragments of
abnormal vessel wall. The patient was a 77-year-old man with 3-vessel disease, and the filter was deployed for
28 minutes.
Fig 6. Trichrome stain demonstrating fibrocalcific atheroma. Stain highlights fibrocalcific atherosclerotic wall
admixed with fibrous and elastic tissue and microscopic collections of clot and calcium deposits. The patient was
a 75-year-old man who underwent aortic and mitral valve replacement, and filter dwell was 32 minutes.
Deployment of the filter was facile, and no filter-
related adverse events occurred. Two patients did not
receive the filter device. One patient had a “porcelain”
aorta detected intraoperatively, and the procedure was
performed off-pump. In the other patient it was difficult
to insert the filter. The latter case occurred very early in
the study, and there were no further technical difficul-
ties in filter deployment.
Clinical follow-up yielded no strokes that were
observed in the perioperative or postoperative follow-
up. Immediately after the operation, 4 (5%) patients
had a short transient delirium ranging from 24 to 48
hours after surgery. At time of discharge, gross neuro-
logic examination did not reveal any pathologic abnor-
malities, such as deficits in memory or any focal symp-
toms. There was one death unrelated to the filter in a
high-risk patient unable to be weaned from bypass; this
patient already had a preoperatively severely decreased
left ventricular ejection fraction. One patient had a
myocardial infarction after CABG.
Visual inspection after filter removal revealed hard
granular particles, soft material, or both in 74 (96%) of
the 77 filters (Fig 3). The average number of particulate
emboli was 5 to 10 per filter, ranging from 1 to 20 per
filter. The average particle size was 0.6 mm, ranging
from 0.1 to 6 mm. The majority of filters (66 [85.7%])
were analyzed by either scanning electron microscopy
(12 [18%]) to evaluate thrombogenicity of the device
or by histology (44 [66%]) to evaluate the actual com-
position of the particles. A total of 12 (15.5%) filters
did not undergo pathologic analysis for varied reasons,
including risk related to blood-borne pathogens and
loss of particles in processing.
Scanning electron microscopy examination of 12 fil-
ters show filter mesh surfaces that are mostly clear with
scattered evidence of red blood cells, fibrin cells, and
activated platelets, usually numbering less than 10 par-
ticles in total. One filter did show evidence of what
appeared to be a spot of thrombus; this filter was one of
the initial units used early in the study. None of the
scanning electron microscopy photographs demon-
strate the presence of atheromatous material or vessel
wall. One filter contained a small but fresh thrombus
along the central seam near the luminal center of the
filter mesh. This single particle was characterized by
fibrinous material adherent to the meshwork admixed
with leukocytes, erythrocytes, and platelets, as verified
in a subsequent histologic analysis. No other abnor-
malities were found within the remaining portions of
this filter. All other filters analyzed did contain patchy
focal sites of fibrin with platelet deposition. Although
every filter examined showed evidence of platelet and
fibrin deposition, when all the focal sites are combined
together, the total area of obstruction was less than 5%
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Fig 7. Elastica van Gieson stain demonstrating the presence of needle-shaped cholesterol fragments characteris-
tic of the grumous portion of atheromatous plaque. The patient was a 67-year-old man with 3-vessel disease, and
the filter was deployed for 30 minutes.
of the total filter mesh pore surface and was not con-
sidered to be of any clinical significance (Fig 4).
Histologic results of the 44 filters revealed significant
evidence of fibroatheromatous material, including nee-
dle-shaped cholesterol fragments and loose myxoid tis-
sue containing collagen and spindle cells. The cell
types, organized into categories of interest, were as fol-
lows: presence or absence of platelet-fibrin deposition,
true thrombus (blood clot), grumous portion of plaque-
cholesterol, fibrous atheroma or fibrous cap (with or
without calcification), and normal vessel wall (Table
III). By far, the most common finding was the presence
of fibroatheroma or fibrous cap in 66% (n = 29) of the
samples, two of which contained discrete punctate foci
of calcified material (Figs 5 and 6). Fibrin, with and
without the obvious presence of platelets, was associat-
ed with 36% (n = 16) of the filters. True thrombus,
including clot rich with erythrocytes, was found in 25%
(n = 11) of the filters. One of these filters was used dur-
ing a procedure in which the thrombus was excised
directly from the left atrium. Because the particles were
removed from the filter mesh to enable histopathologic
analysis, the origin of the thrombus could not be deter-
mined. Grumous portion of the atheromatous plaque
(needle-shaped cholesterol fragments highlighted by
trichrome and elastica van Gieson stains) was found in
1 (2%) filter (Fig 7). Normal vessel wall was identified
in 3 filters; however, in at least 4 other filters, the core
laboratory reported the tissue fragments as small, mak-
ing definitive classification between fibrous atheroma
and tangentially sectioned (normal) vessel wall difficult.
An interesting finding in one filter was the presence of
a small aggregate of mature hyaline cartilage, likely to
be from the costochondral junction of a rib. The case
was a regular coronary bypass operation, and the filter
dwell was 32 minutes.
Discussion
The issue of neurologic deficits occurring in cardiac
operations is gaining increased attention because of its
severity. In recent years, there has been an increasing
awareness of atheromatous disease within the aorta and
its role as a source of emboli during cardiac surgery.
Recent studies have demonstrated a link between the
degree of embolic material and neurologic damage.9,10
The evidence in these studies over the past 14 years
shows that as the age of the patients undergoing cardiac
operation procedures with cardiopulmonary bypass has
increased, the central nervous system complications
associated with the surgery have increased.
Catastrophic neurologic sequelae of bypass surgery,
such as stroke and diminished mentation, occur in part
because cerebral arteries are blocked by emboli
released during specific surgical events. Emboli are
released in significant amounts, primarily at the incep-
tion of bypass and at the release of aortic clamps.9,14,16
The emboli released at the inception of bypass are
thought to be small gaseous emboli generated in the
bypass system and can be removed by extracorporeal
filter membrane within the cardiopulmonary bypass
system. The emboli released during removal of aortic
clamps are in both particle and gaseous form because
of debris from atheromatous plaques in the ascending
aorta and air released during manipulation of the heart.
The described filter and cannula system is a first-gen-
eration device demonstrating the concept of intra-aor-
tic filtration and is designed to address a potential
source of complications, specifically particulate emboli
generated during aortic manipulation. This clinical
study demonstrates that this system is safe and easy to
use and that the filter clearly captures particulate
emboli, ranging from 0.1 to 6.0 mm, that are readily
visible to the naked eye.
The pore size of the filtration system of 120 µm
enables this device to capture particles greater than 120
µm. In the 1997 study by Barbut and associates,10
which characterized emboli size by using TEE and
transcranial Doppler studies, 72% of the particles were
seen to be greater than 0.6 mm in size, with 28% of the
particles greater than 1.0 mm, 44% between 0.6 and 1.0
mm in size, and 27% being 0.6 mm or less in diameter.
This is well above the 0.12-mm diameter filter pore
size of the device. On the basis of these data, the filter
device is well designed to capture a majority of partic-
ulate emboli that may be generated during the course of
the cardiac operation.
The scanning electron microscopy findings con-
firmed device safety relating to thromboresistance of
the filter mesh, as demonstrated by the insignificant
degree of platelet adhesion on the surface of the filter.
In one patient in whom thrombus was detected, the pro-
cedure involved excising thrombus directly from the
left atrium. Thus although the origin of the thrombus
could not be determined from the specimen, it is plau-
sible that the thrombus originated from the left atrium.
There did not appear to be a correlation in filter dwell
time and the microscopy findings of thrombus.
Because 5% or less of the total filter mesh area was
obstructed in all cases, these findings were not consid-
ered to be of clinical significance.
The histologic findings raise questions with regard to
the incidence, quantity, and type of surgical debris
released into the central circulation that have been
heretofore undocumented in the surgical literature. The
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remarkable predominance of particles of fibroathero-
matous origin (66%) must give us pause as to the
amount of debris typically released into the circulation
because of routine surgical procedures. Moreover,
these preliminary findings beg a mandate for manage-
ment of such surgical debris, which intuitively must be
minimized or eliminated if possible. Theoretically, pre-
vention of the embolization of these particles to the
brain would reduce the risk of neurologic deficit.
Furthermore, although cerebral injury relating to
emboli generation is considered to be one of the most
devastating results, other complications relating to sys-
temic injury (eg, renal, pulmonary, and peripheral vas-
culature) that may be due to emboli generation during
cardiac operations remain problematic as well.
The postoperative gross neurologic follow-up in the
examined patients was completely uneventful, except
for a brief period of fully reversible postoperative delir-
ium in 5% of the patients. This low incidence of neuro-
logic events was present despite the fact that complex
cardiac surgical procedures were included.
Clearly, further research and clinical studies are need-
ed to fully evaluate and quantify these preliminary find-
ings. Specific efforts must be undertaken to understand
the origin and the clinical significance of the capture of
particulate debris during routine and complex cardiac
operations. Clinical studies are underway (International
Council on Emboli Management) to more fully explore
the efficacy of emboli management with intra-aortic fil-
tration. International Council on Emboli Management is
planned as a prospective, consecutive observational
study to evaluate the potential benefits of intra-aortic fil-
tration by means of collection of clinical data related to
preoperative disposition, surgical and procedural
details, evaluation of the aorta with the degree of aortic
manipulation, and postoperative clinical outcomes.
Conclusion
Intra-aortic filtration is a feasible method of captur-
ing particulate emboli in patients undergoing car-
diopulmonary bypass during cardiac surgery. The filter
design is simple, and implementation is easily incorpo-
rated into standard cardiac procedures. Histologic
analysis confirmed the presence of atheromatous mate-
rial recovered from the filters. More prospective studies
are needed to fully demonstrate the efficacy and clini-
cal benefit of intra-aortic filtration in both high-risk and
low-risk patients undergoing cardiac operations.
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Discussion
Dr G. Hossein Almassi (Milwaukee, Wis). I have a couple
of questions. It appears that you did your proximal anasto-
mosis on a side-biting clamp after the crossclamp has been
released. Do you have any data in which you use only a sin-
gle crossclamp, do all your anastomoses, and compare those
data with data from this set of patients to see what the differ-
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ence is in terms of the contribution of the side-biting clamp
to the release of this material?
Second, for the material that you recovered, did you corre-
late that with your echocardiographic findings in terms of the
nature of the aortic wall in relation to the amount and the
nature of the material you recovered?
Dr Reichenspurner. To address your first question, in most
of the patients I used a side-biting clamp to do the proximal
anastomosis. However, 20% of the procedures were done with
the proximal procedures done on the clamped aorta. As you
saw before, over 90% of the filters did have material in them
independent of whether we used the partial crossclamping.
We are so far not able to correlate the amount of material
captured according to the degree of the condition of the aorta
as verified by TEE.
Dr Mohamed Emara (Cairo, Egypt). I have a question
and a comment. Do you think that you have to put this filter
in earlier than bypass, especially for valve cases, where you
can embolize things during manipulation of the heart?
Your results are perfect. What about the air embolism espe-
cially in valve cases?
Dr Reichenspurner. At the beginning, we were concerned
whether if you leave the filter in too long, there may be evi-
dence of thrombosis that might obstruct quite a bit of the area
of the filter, leading to a higher resistance and an increased
afterload for the heart. That is why we started off with rela-
tively short dwell times, which were gradually increased.
However, even in filters that stayed in for about an hour, we
did not see an obstruction of more than 5% of the mesh area.
Therefore it is probably safe to leave it in longer. When you
clamp the aorta, there is already the possibility of generation
of particulate emboli, and therefore it would be justified to
put it in earlier.
Air embolism is certainly a concern with transcranial
Doppler studies. It is always hard to differentiate on transcra-
nial Doppler scanning between particulate and gaseous
emboli. I think that you might be able to catch gaseous
emboli, but I do not think you will actually get them out
because once you pull the filter back, you squeeze the filter
through the side port, and that will probably squeeze the air
out again. Therefore I do not think you will get rid of all the
air, but you will definitely get rid of the particulate material,
which is probably the more dangerous material.
Dr Hazim J. Safi (Houston, Tex). Have you mapped the
ascending aorta by using TEE? Without the hand-held probe,
we have had little luck in detecting atheromatous debris or
plaque in the ascending aorta.
Dr Reichenspurner. You are fully right. It is a challenge to
assess the atheromatous, diseased ascending aorta because it
is not easily accessible, but we did use TEE before, and in
about half of the patients we used epiaortic scanning during
the surgical procedures, which is probably the best way to
verify aortic disease. But as mentioned before, we did not
find a correlation of the degree of the aortic disease and the
amount of captured material.
Dr Paul Kurlansky (Miami Beach, Fla). I congratulate you
on a potentially extremely useful addition to the cardiac sur-
gical armamentarium. I would like to recommend that in your
future studies you assess not only neurologic function but
renal function as well because I suspect that you will cause a
significant decrease in postoperative renal complications.
Dr Reichenspurner. Thank you very much.
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